Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer

Clinical Cancer Research

Volumn 10, Issue 11, 2004, Pages 3629-3638

  Tamoto, Eiji ^a   Tada, Mitsuhiro ^b   Murakawa, Katsuhiko ^a   Takada, Minora ^a   Shindo, Gaku ^a   Teramoto, Ken Ichi ^a   Matsunaga, Akihiro ^a   Komuro, Kazuteru ^a   Kanai, Motoshi ^a   Kawakami, Akiko ^c   Fujiwara, Yoshie ^c   Kobayashi, Nozomi ^c   Shirata, Katsutoshi ^c   Nishimura, Norihiro ^c   Okushiba, Shun Ichi ^a   Kondo, Satoshi ^a   Hamada, Jun Ichi ^b   Yoshiki, Takashi ^b   Moriuchi, Tetsuya ^b   Katoh, Hiroyuki ^a  

^a Graduate School of Medicine   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c GeneticLab Co   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; COMPLEMENTARY DNA; MEMBRANE RECEPTOR;

ACCURACY; ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CELL CYCLE; CONTROLLED STUDY; ESOPHAGUS CANCER; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; UNINDEXED SEQUENCE;

ALGORITHMS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE PROGRESSION; DNA, COMPLEMENTARY; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGANDS; LINEAR MODELS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 2542590283     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0048     Document Type: Article

References (43)

1. Xiao ZF, Yang ZY, Liang J, et al. Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 2003;75:331-6.
2. Mariette C, Balon JM, Piessen G, Fabre S, Van Seuningen I, Triboulet JP. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 2003;97:1616-23.
3. Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177-83.
4. Kimura H, Konishi K, Arakawa H, et al. Number of lymph node metastases influences survival in patients with thoracic esophageal carcinoma: therapeutic value of radiation treatment for recurrence. Dis Esophagus 1999;12:205-8.
5. Porte H, Triboulet JP, Kotelevets L, et al. Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. Clin Cancer Res 1998;4:1375-82.
6. Wang LS, Chow KC, Wu CW. Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate. Br J Cancer 1999;80:1617-22.
7. Xu Z, Wang MR, Xu X, et al. Novel human esophagus-specific gene clorf10: cDNA cloning, gene structure, and frequent loss of expression in esophageal cancer. Genomics 2000;69:322-30.
8. Wang Q, Yang C, Zhou J, Wang X, Wu M, Liu Z. Cloning and characterization of full-length human ribosomal protein L15 cDNA which was overexpressed in esophageal cancer. Gene 2001;263:205-9.
9. Kato K, Hida Y, Miyamoto M, et al. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 2002;94:929-33.
10. Miyazaki T, Kato H, Fukuchi M, Nakajima M, Kuwano H. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int J Cancer 2003;103:657-63.
11. Miyazaki T, Kato H, Nakajima M, et al. FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 2003;89:140-5.
12. Shiraishi T, Mori M, Tanaka S, Sugimachi K, Akiyoshi T. Identification of cystatin B in human esophageal carcinoma, using differential displays in which the gene expression is related to lymph-node metastasis. Int J Cancer 1998;79:175-8.
13. Ding Y, Shimada Y, Gorrin-Rivas MJ, et al. Clinicopathological significance of human macrophage metalloelastase expression in esophageal squamous cell carcinoma. Oncology 2002;63:378-84.
14. DeRisi J, Penland L, Brown PO, et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996; 14:457-60.
15. Hasegawa S, Furukawa Y, Li M, et al. Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res 2002;62: 7012-7.
16. Huang E, Cheng SH, Dressman H, et al. Gene expression predictors of breast cancer outcomes. Lancet 2003;361:1590-6.
17. Sobin LH, Wittekind C. TNM classification of malignant tumours, 6th ed. New York: WileyLiss, 2002. p. 60-64.
18. Durbin B, Rocke DM. Estimation of transformation parameters for microarray data. Bioinformatics 2003;19:1360-7.
19. Redner RA, Walker HF. Mixture densities, maximum likelihood and the EM algorithm. SIAM Review 1984;26:195-239.
20. Duda RO, Hart PE, Stork DG. Pattern Classification, 2nd edition. New York: John Wiley & Sons, 2001.
21. Efron B. The bootstrap method for assessing statistical accuracy. Behaviormetrika 1985;17:1-35.
22. Whitney AW. A direct method of nonparametric measurement selection. IEEE Trans. Comput 1971;20:1100-3.
23. Olshen AB, Jain AN. Deriving quantitative conclusions from microarray expression data. Bioinformatics 2002;18:961-70.
24. Tarjan R. Depth-first search and linear graph algorithms. SIAM J Comput 1972;1:146-60.
25. Dijkstra EW. A note on two problems in connection with graphs. Numer Math 1959;1:269-71.
26. Specht DF. Probabilistic neural networks. Neural Networks 1990; 3:229-36.
27. Freund Y, Schapire R. A decision-theoretic generalization of online learning and an application to boosting. J Comput Syst Sci 1997;55: 119-39.
28. Xu SH, Qian LJ, Mou HZ, et al. Difference of gene expression profiles between esophageal carcinoma and its pericancerous epithelium by gene chip. World J Gastroenterol 2003;9:417-22.
29. Lu J, Liu Z, Xiong M, et al. Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus. Int J Cancer 2001;91:288-94.
30. Adachi M, Taki T, Higashiyama M, Kohno N, Inufusa H, Miyake M. Significance of integrin alpha5 gene expression as a prognostic factor in node-negative non-small cell lung cancer. Clin Cancer Res 2000;6:96-101.
31. Li X, Yang Y, Hu Y, et al. Alphavbeta6-Fyn signaling promotes oral cancer progression. J Biol Chem 2003;278:41646-53.
32. Koseki T, Inohara N, Chen S, Nunez G. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci USA 1998;95:5156-60.
33. Shimonishi T, Miyazaki K, Kono N, et al. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma. Hum Pathol 2001;32:302-10.
34. Yamashita K, Mori M, Kataoka A, Inoue H, Sugimachi K. The clinical significance of MMP-1 expression in oesophageal carcinoma. Br J Cancer 2001;84:276-82.
35. Yamashita K, Mori M, Shiraishi T, Shibuta K, Sugimachi K. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin Cancer Res 2000;6:1169-74.
36. Mathew R, Khanna R, Kumar R, Mathur M, Shukla NK, Ralhan R. Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications. Cancer Detect Prev 2002;26: 222-8.
37. Mori M, Mimori K, Sadanaga N, et al. Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma. Int J Cancer 2000;88:575-8.
38. Kitadai Y, Amioka T, Haruma K, et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer 2001;93:662-6.
39. Ariza ME, Broome-Powell M, Lahti JM, Kidd VJ, Nelson MA. Fas-induced apoptosis in human malignant melanoma cell lines is associated with the activation of the p34(cdc2)-related PITSLRE protein kinases. J Biol Chem 1999;274:28505-13.
40. Nozoe T, Korenaga D, Itoh S, Futatsugi M, Maehara Y. Clinicopathological significance of pRb2/p130 expression in squamous cell carcinoma of the esophagus. J Cancer Res Clin Oncol 2002;128:691-6.
41. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell 1995;83:835-9.
42. Kroll TG, Sarraf P, Pecciarini L, et al. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma. Science 2000;289:1357-60.
43. Xu Y, Selaru FM, Yin J, et al. Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. Cancer Res 2002;62:3493-7.